Maravai LifeSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Maravai LifeSciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-0.02 | $-0.01 | -100.0 % |
Q1 | 2024-05-08 | $-0.02 | $-0.03 | 33.3 % |
Q4 | 2024-02-22 | $0.01 | $-0.01 | 200.0 % |
Q3 | 2023-11-07 | $-0.01 | $0.01 | -200.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $65.20M | $67.55M | -3.48 % |
Q2 | 2024-08-07 | $73.40M | $71.63M | 2.47 % |
Q1 | 2024-05-08 | $64.18M | $60.55M | 5.99 % |
Q4 | 2024-02-22 | $74.14M | $64.38M | 15.2 % |
Maravai LifeSciences (MRVI) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.02, which missed the estimate of $-0.01.
The Actual Revenue was $65.2M, which missed the estimate of $67.5M.
Browse earnings estimates, EPS, and revenue on all stocks.